Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
581 to 600 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| P01NS090994 | MicroRNA-Dependent Regulation of Synaptic and Behavioral Plasticity in Drosophila | 1 | 2020 |
| P30AG013846 | Boston University Alzheimer's Disease Center | 1 | 2020 |
| P30AG019610 | Arizona Alzheimer's Disease Core Center | 1 | 2020 |
| P30AG028383 | University of Kentucky Alzheimer's Disease Core Center | 1 | 2020 |
| P30NS050274 | JHU Center for Neuroscience Research | 1 | 2020 |
| P50CA098258 | MD Anderson Gynecologic SPORE for Uterine Cancers | 1 | 2020 |
| P50MH094268 | Gene-Environment Interactions for Cortical Development and Schizophrenia | 1 | 2020 |
| P50NS062684 | Pacific Udall Center | 1 | 2020 |
| R00DA040744 | Neuronal subtype and circuit-specific epigenetic mechanisms in addiction | 1 | 2020 |
| R00HL130574 | Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosis | 1 | 2020 |
| R01AA024659 | Prenatal microRNA neuro-therapeutics for fetal alcohol exposure | 1 | 2020 |
| R01AG053960 | Tau-Spliceosome Interactions in Alzheimer's Disease | 1 | 2020 |
| R01AI125615 | Control of B cell development and effector functions by microRNA-142 | 1 | 2020 |
| R01AR056645 | Role of miR-17-92 miRNAs in skeletal development and bone homeostasis | 1 | 2020 |
| R01AR072401 | Mechanisms of Lupus Disease Transition and Hydroxychloroquine Immune Modulation | 1 | 2020 |
| R01CA197098 | Roles of miR-129 in colorecal cancer | 1 | 2020 |
| R01CA200651 | Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization | 1 | 2020 |
| R01CA202797 | MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer | 1 | 2020 |
| R01CA206027 | PQ1: Identification and characterization of genetic alterations for the progression of pre-neoplastic lung lesions by using novel PDx models and deep sequencing | 1 | 2020 |
| R01CA206444 | Rac1 GTPase in tumorigenesis and progression of pancreatic cancer | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=30